The literature indicates potential interactions between some disclosed ingredients and certain medications, particularly berberine with diabetes and blood pressure medications
These impacts are especially noticeable in the first four to eight weeks of a patients GLP-1 weight loss journey, leading to issues like constipation, nausea, bloating, vomiting, and other gastrointestinal discomforts
doi: 10.3233/JAD-215376 84
If you stop GLP-1 medications like tirzepatide, research shows several common outcomes: Appetite increases Calories consumed gradually rise Weight regains within weeks to months Blood sugar improvements may diminish This is not a sign of failure, its simply biology
More from the blog Continue reading The Pentagon Is Screening Troops for Low Testosterone Where Peptides Fit the Hormone-Optimization Moment Defense Secretary Pete Hegseth announced annual testosterone screening for service members over 30